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Alcohol and drug addiction have widespread detrimental effects, and physical and psychological 
costs on individuals, families, communities and society. There is accumulating evidence 
suggesting that impulsive behaviours (urgency/delay discounting, lack of premeditation/thought, 
lack of perseverance and sensations seeking/risk taking) and the symptoms of Attention Deficit 
Hyperactivity Disorder (inattention, hyperactivity and impulsivity) are connected to problematic 
alcohol and drug use. However, there is little research on impulsivity and disorders of Attention 
Deficit Hyperactivity Disorder (ADHD) in Substance Use Disorder (SUD). This study assessed 
23 adult men in residential treatment in Christchurch (New Zealand) for SUD and 23 males 
aged-matched non-SUD controls on measures of impulsivity (UPPS-P Impulsive Behavior 
Scale) and ADHD (the Adult ADHD Self-Report Scale ASRS-v1.1 Symptom Checklist) 
symptoms. Those with SUD reported significantly higher impulsivity and ADHD 
symptomology, suggesting a link between these constructs and drug addiction. Overall, these 
findings provide much needed research into the prevalence of impulsivity and ADHD symptoms 







Drug addiction affects the lives of many people and without discrimination of social 
class, education, gender or race. Some individuals caught in drug addiction lose their family and 
friends, their livelihood, homes and possessions, and some even lose their lives. Prolonged use of 
drugs can lead to not only an increased tolerance and clinical addiction for the drug, but also the 
desire to carry out various rituals associated with the drug use (Friedman, Dar, & Shilony, 2000). 
Once the addiction reaches a clinical level, a compromise in personal boundaries and moral 
behaviours are often seen, along with diminished self-care and self-control. Once drug use 
becomes addictive it takes over everything that was previously important: children, partners, 
family members, friends, health and self-care all become second to the drug (el-Guebaly, Mudry, 
Zohar, Tavares, & Potenza, 2011). 
The notion that someone with an addiction could have an “addictive personality” has 
gained much publicity. However, there is no solid and consistent evidence to support this theory 
(Kerr, 1996). There is no unique constellation or specific personality profile that predisposes an 
individual to becoming addicted to drugs. Kerr (1996) confers that compulsiveness is important 
to consider in addiction, since there is no personality type that fits a person addicted to alcohol or 
drugs, and free choice is seen to be involved in drug use. Impulsivity is also considered to be a 
critical factor in models of addiction along with other disorders also linked to impulse deficits 




A model of addiction that now receives very little attention is the moral model. This 
model views drug addiction as a choice whereby the drug addicted individual is in full control of 
their choices and their behaviour is completely voluntary. This view does not explain why 
addiction involves the continuation of the drug taking behaviour despite the detrimental and 
adverse consequences, and sincere desire to stop (Kerr, 1996). It has been argued that 
compulsivity is the central feature of addiction and that it demonstrates an inability for freedom 
of choice or will (Kerr, 1996). However, all behaviours have an element of biology and 
compulsivity is easily seen through the observation of particular behaviours that involve 
voluntary actions (Heyman, 2013).  
Izquierdo and Jentsch (2012) found that difficulty in disengaging from an ongoing 
behaviour reflected a tendency for habitual or compulsive responses and that over time the 
effects of using drugs can become more habitual, compulsive, and less pleasurable. The two 
prominent models used today are the psychological model and the medical model (Eysenck, 
1997). The medical model defines addiction as a mental disorder (Hendon, Melberg, & 
Rogeberg, 2013) which is in alignment with the description of addiction in the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5: American Psychiatric 
Association, 2013).  
The DSM-5 lists addiction as Substance Use Disorder (SUD). It states that drugs 
intensely activate the reward centre of the brain which reinforces the drug taking behaviour. 
Individuals that have low levels of self-control, reflected as an impairment of the brain’s 
inhibitory mechanisms, may have an increased disposition to developing a SUD. The DSM-5’s 
definition of addiction, consistent with the medical model, confers that drug addiction is a 
disease that is characterised by little to no control over the compulsive use of a drug, resulting in 
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recurrent relapse (Henden et al., 2013). However, the problem with the medical model is that it is 
based in scientific methods and is really only able to incorporate phenomena that is measurable 
and quantifiable (Zigmond, 2012). 
The psychological model is a theory that explains specific psychological processes, 
predicts outcomes, and looks at the emotional and cognitive processes that motivate our 
behaviour (Ashar et al., 2016). However, on their own, the psychological and medical model do 
not explain or encompass all aspect of human functioning and behaviour. Therefore, both models 
are useful to incorporate when working with addiction. One aspect of behaviour – impulsivity 
has been associated with illicit drug use and is worthy of further research. Impulsivity is well 
documented and researched as a construct implicated in the use of drugs and drug addiction 
(Weafer & Wit, 2013). The personality facets of impulsivity have been thoroughly researched 
and have also been shown to be a very prominent feature of Attention Deficit/ Hyperactivity 
Disorder (ADHD) (Fernando et al., 2011).  
 
Impulsivity  
Although drug addiction may appear compulsive, for some, their drug use could be 
motivated by a desire to eliminate or reduce feelings of stress and anxiety (el-Guebaly et al., 
2011). Yet for others it may be due to deficits in their decision making or a lack of control over 
their impulses. Li et al., (2012) reported that there are marked differences in the characteristics 
between control users and substance users with research showing a high score for impulsivity in 
substance users. The research also found that impulsivity is a high-risk factor for the onset and 




Li et al. (2012) also reported that some studies have found that impulsivity was 
significantly and positively correlated to the quantity of illicit drugs used in a lifetime, while the 
age of using a substance for the first time was negatively correlated to impulsivity measures. 
Impulsivity has been broadly understood as a predisposition for rapid and unplanned reactions to 
stimuli (both internal and external) without regard to negative consequences for oneself or others 
(Liu et al., 2012). Consequently, impulsivity leads to an array of problems with regards not only 
to impulsive drug taking but also when it comes to other high risk activities.  
By definition, impulsivity is defined as encompassing two elements – impulse action and 
impulse choice. Impulse action involves the inability to withhold a response which reflects poor 
response inhibition, whereas impulse choice involves an elevated preference for instant 
gratification over a more beneficial delayed reward (Brevers et al., 2012). In drug addicted 
individuals, impulsive action is demonstrated by a difficulty inhibiting or controlling a response 
(i.e., to not take a drug in the moment it is made available); and impulse choice is displayed by a 
difficulty delaying gratification (i.e., not take the drug on offer right now for the prospect of 
having better health, relationships and happiness in the future; Weafer & Wit, 2013).  
Controlled decision making requires the ability to exert inhibitory control over impulsive 
responding. However, it is not common practice for all people to deliberately and carefully 
consider all of the pros and cons of an action before taking it, and especially not those with an 
impulsive disposition (Kerr, 1996). In studies on impulsivity using intertemporal choice tasks, 
impulsive choice can be measured. In these tasks, participants have to make a choice between an 
immediate but small reward and a delayed but larger reward. Greater impulsive choice has been 
repeatedly reported in those with substance use disorders. Moreover, in animal studies, a pre-
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existing impairment in impulsive choice has been shown to predispose its subjects to higher 
quantities of cocaine self-administration and of reinstatement of drug-seeking behaviour.  
Impulsive choice appears to be associated with selection biases towards the immediate 
reward (drug) rather than the longer term benefits that are associated with health, family or 
employment (Voon et al., 2010). A study by Moody, Franck, Hatz, and Bickel (2016) researched 
the relationship between the use of multiple drugs and the rate of delay discounting (reduced 
estimate of future rewards i.e., wanting it now), an indicator of impulsivity. They reported that 
80 percent of drug users regularly use more than one drug, and found that substance users have 
far higher discounting rates compared to non-substance users, with the rate of discounting 
increasing with the number of substances regularly used.  
Liu et al. (2012) also found that higher discount rates are consistently found amongst 
substance users. A study that measured specific impulsive behaviours of delay discounting and 
risk-taking, reported that both of these constructs are highly associated with drug use 
(Bornovalova, Daughters, Hernandez, Richards, & Lejuez, 2005).  Another study found similar 
results where dependent Marijuana users which demonstrated a tendency toward increased delay 
discounting on impulsiveness scales when compared to controls (Gruber, Silveri, Dahlgren & 
Todd, 2011). It is well researched that impulsivity plays a large role in drug use, showing that 
those with SUD tend to go for immediate although smaller rewards rather than delayed larger 
rewards (Torok, Darke, & Kaye, (2012). 
Research on chronic smokers of Marijuana found that participants who had use of 
Marijuana early in their lives also demonstrated an increase in impulsivity compared to the 
control participants. This increased level of impulsivity may have contributed to the initial use of 
Marijuana or the inability to discontinue using the substance (Gruber et al., 2011). A further 
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indicator of impulsivity - sensation seeking, has also been seen to play a crucial role when it 
comes to susceptibility to alcohol and drug use.  It has been found that for those who tested as 
high sensation seekers, the use of alcohol was twice as high as that of low sensation seekers.  
Sensation seeking has been defined as a trait which involves seeking complex, novel, 
varied, and intense experiences and sensations, along with the willingness to have experiences 
that may involve social, legal, physical and financial risks (Donohew, Zimmerman, Cupp, 
Novak, Colon, & Abell, 2000). In research conducted by Donohew et al., (2000) it was found 
that individuals with high levels of sensation seeking were found to be receptive to stimuli, both 
internal and external, that is intense, novel and arousing. Other stimuli that produces arousal at 
lower levels is considered ‘boring’ and may result in the high sensation seeker looking for 
alternative sources of stimulation. Low sensation seekers tend to look for stimuli that is less 
intense and arousing, and preferring familiar and less complex stimuli.  
It has been found that sensation seeking is highly related to impulsivity, particularly with 
the lack of planning and forethought, and risk taking, hence making the high sensation seeker 
more likely to engage in alcohol and drug use (Donohew et al., 2000).  Numerous studies have 
shown that drug use is related to a reduction in cognitive functioning, and specifically with 
behavioural inhibition (Gruber et al., 2011). Given that impulsivity is a prominent feature of 
addiction involving poorly conceived risky actions that are prematurely expressed and resulting 
in undesirable outcomes, highlights the importance for a requirement of further research and 







Impulsivity as a construct on its own has been related to a number of psychiatric 
disorders, furthermost and markedly ADHD (Fernando et al., 2011). ADHD has become a more 
commonly recognised childhood behavioural disorder and is characterised with chronic problems 
of hyperactivity, inattention, and impulsivity (Glass & Flory, 2012). Given that functional 
impairments academically and socially are commonly associated with ADHD, it is found that 
this may consequently lead to involvement in deviant behaviour and drug use. It has been found 
that children with ADHD have an increased risk of alcohol abuse and dependence in adulthood. 
It has also been found that those with childhood ADHD have higher tolerance and larger use of 
alcohol and other drugs in their adolescence (Molina, Walther, Cheong, Pedersen, Gnagy, & 
Pelham, Jr, 2014).  
Many children with the symptoms of ADHD go undiagnosed, untreated and unmanaged, 
and with these symptoms persisting into adolescence and adulthood, they are far more likely to 
develop SUD (Kaye et al., 2013). With the symptoms of ADHD first manifesting in childhood, it 
has been found that in 70% of cases the behaviours of ADHD persist into adulthood (Torok et 
al., 2012). Research has shown that those with a diagnosis of childhood ADHD persisting into 
adulthood, have a 52% higher chance of developing an addiction to drugs (Matthys, Joostens, 
Stes, Tremmery, & Sabbe, 2013). There has been some research that suggests treatment for 
ADHD in children may produce a beneficial effect when it comes to the prevention of a drug 
addiction later in life (Garcia, 2013). However approximately only 4% of the general adult 
population are diagnosed with ADHD, and it is estimated that this figure would be three times 
higher amongst adult substance users (Torok et al., 2012).   
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With a diagnosis of ADHD, individuals with a co-existing diagnosis of SUD, have an on-
going and persistent problem with drug use. More research is required in order to accurately 
diagnose individuals who possibly have an untreated diagnosis of ADHD along with a diagnosis 
of SUD. It has been found that it is difficult to make an accurate diagnosis in individuals that are 
not fully abstinent as the symptoms of ADHD can be exacerbated by illicit drug use. There is 
research that indicates that observation as well as a formal assessment (i.e., diagnostic scales), is 
required for adequate detection of ADHD for drug users. In the study by Matthys, Joostens, Stes, 
Tremmery, and Sabbe (2013) it was found that there was a significant difference between those 
addicted to drugs that were in treatment, and those that were not being treated, when it came to 
the possibility of diagnosing and treating the symptoms of ADHD.  
A study of cocaine users seeking treatment showed that 35% of participants met the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-
TR: American Psychiatric Association, 2000) criteria for ADHD, and close to one in four with a 
SUD also had ADHD (Keith, Rapgay, Theodore, Schwartz, & Ross, 2015). ADHD is associated 
with earlier onset and greater severity of SUD and as with other disorders, there is a tendency to 
self-medicate to alleviate or manage the symptoms (Kaye, Darke, & Torok, 2013). It has been 
well documented that ADHD is associated with SUD and it is estimated that among the 
population of those with SUD, 23% also meet criteria for ADHD (Kaye et al., 2013).  
In Kaye et al.’s (2013) study, 45% of participants with SUD screened positive for 
ADHD. Only 17% had been previously diagnosed as having ADHD. It is plausible that those 
with ADHD are under identified amongst those diagnosed with SUD, and research has shown 
that those with SUD are seldom concurrently diagnosed with ADHD leaving the symptoms 
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untreated and unmanaged (Kessler et al., 2006). A further implication of ADHD symptoms is the 
affect they have on the frequency of drug taking and quantity of drugs used.  
Research by Horner, Scheibe, and Stine (1996) looked at the link between ADHD and 
cocaine use, and found that participants with higher scores for ADHD used higher quantities of 
cocaine and self-medicated due to the initial therapeutic effect. Unfortunately, this therapeutic 
affect does wear off and a dependence is formed along with the requirement for a remedy for the 
negative symptoms associated with withdrawal. In treatment settings some of the main 
symptoms of ADHD such as impulsivity, impatience and poor organisational skills, results in 
frequently missed appointments, inconsistencies in treatment, and repeated relapses, all of which 
interfere with recovery (Keith et al., 2015). This can make working with these individuals far 
more challenging for Alcohol and Other Drug (AOD) practitioners and consequently treatment is 
far less effective.  
It is also worth noting that the main symptoms of ADHD such as poor concentration, 
limited attention span, restlessness, impulsivity and frustration, interfere with SUD treatment 
(Horner et al., 1996). These symptoms of ADHD can also be enhanced by withdrawals and 
cravings for drugs, making a sound diagnosis and treatment particularly problematic, especially 
when the individual is not fully abstinent (Matthys et al., 2013). When treating an individual for 
long term sobriety or abstinence, it is also important to consider if the symptoms of ADHD, 
specifically the impulsivity, were present prior to using drugs, or whether it is a product of the 
affects of a drug addiction (Weafer & Wit, 2013).  
A well-designed study by Kaye et al. (2013) confirmed that ADHD is a frequent 
comorbid disorder with not only those being treated for SUD, but also in those using 
psychostimulant drugs. In this study 50% of those using psychostimulant drugs who were not 
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receiving treatment, screened positive for ADHD. The results demonstrate the importance of 
screening for ADHD for those with SUD, and also for those that are not receiving treatment.  
Considering there is a threefold increase in prevalence of ADHD symptoms among drug users, 
there are some important issues that arise, such as the self-medication of those with ADHD 
symptoms who have a SUD and use illicit psychostimulants.  
This information raises the questions of what comes first, the ADHD or the SUD? Could 
it be that the SUD was preventable if ADHD was diagnosed and treated at an early stage?  
Moreover, if safe ADHD treatment (either pharmacological or psychological) was currently 
available, would it reduce the development of a SUD? Evidence does show that an ADHD 
diagnosis is frequently overlooked and is not commonly diagnosed among SUD patients. So if 
ADHD does go hand-in-hand with the development of a SUD, under-diagnosing or not 
diagnosing ADHD could be highly detrimental (Garcia, 2013). 
Presently there is no evidence-based strategies for treating ADHD when recovering from 
SUD (Keith et al., 2015); however, a study by Matthys et al. (2013) has shown there have been 
positive outcomes for residential patients with coexisting disorders of ADHD and SUD using 
non-pharmacological treatment methods. This is promising and highlights the importance of 
continuing research in this area. However, it has been found that individuals in recovery 
programs with co-occurring ADHD and SUD, have higher rates of failure when it comes to 
completing treatment (Keith et al., 2015). There is difficulty with the treatment of SUD for those 
with the symptoms of ADHD, with higher rates of relapse. It is important to be are aware of the 
impact of compliance to treatment strategies and relapse prevention when it comes to potentially 




The Current Study 
To date there is no routine screening in New Zealand for ADHD amongst those 
presenting with drug addiction issues. Very little is still known about the impact of adult 
diagnoses of ADHD along with SUD, and those who regularly use illicit drugs (Torok et al., 
2012). However, impulsivity and the tendency to engage in risky behaviours has been repeatedly 
shown to be implicated in illicit drug use (Bornovalova et al., 2005). This study explored if 
impulsivity and symptoms of ADHD were related to SUD using only male adults in an AOD 
residential rehabilitation facility. All residents in the AOD facility were abstinent from drug use 
as verified by regular drug testing, however the study focussed on their patterns of behaviour 
prior to them beginning treatment. 
Given so much research has already shown increased impulsivity in SUD, it is important 
to look at the aspects of impulsivity: negative urgency, lack of premeditation, lack of 
perseverance, sensation and positive urgency (Lynam, Smith, Whiteside, & Cyders, 2006). 
Impulsivity is only one of the aspects of ADHD however all the aspects of impulsivity are not 
encompassed or explained by a diagnosis of ADHD alone, therefore requiring further 
investigation.  
Understanding the connection between impulsivity, ADHD and SUD has important and 
relevant implications into the prevention and intervention of drug addiction. There is still little 
research into diagnostic tools for the proper detection of patients with co-existing disorders of 
ADHD and SUD. There is a lack of research on treatment strategies for those with coexisting 
disorders of ADHD and SUD. It is hoped that this study will provide useful information that may 
improve diagnostic tools and treatment strategies in the future, and provide further research into 
this area.  
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The intention of this research is to extend previous studies conducted in the area of 
substance use, impulsivity, comorbid diagnoses of ADHD in SUD, along with important 
demographic factors. It is anticipated that this research will increase knowledge and detection of 
co-existing disorders and personality deficits and thus guide treatment strategies. The main 
hypotheses of the current study are: 
(1) A history of more than two years of alcohol or drug use and a current diagnosis of SUD 
is related to higher rates of impulsivity as determined by the UPPS-P Impulsive 
Behavior Scale (Lynam et al., 2006) on the subscales of negative urgency, lack of 
premeditation, lack of perseverance, sensation and positive urgency.  
(2) A history of more than two years of alcohol and drug use and a current diagnosis of 
SUD is related to higher rates and severity of ADHD symptoms as determined by the 
Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist (Kessler et al., 2005). 
It is expected that the findings will show higher scores in all the subscales for impulsivity and 
higher scores for ADHD symptoms for the drug group when compared to the control group of 














Participants in this study were 46 men aged between 20 and 47 years old who were either 
in the control group (recruited from the general public) or the drug group (in residential 
treatment for SUD). The sample consisted of only males as the AOD rehabilitation centre that 
was agreeable to this research being conducted on their patients, was a male only facility. 
Therefore, only male control subjects were sought and included in this study.  
Potential participants for the control group were verbally screened before partaking in 
this study. They were screened for involvement in AOD services in any capacity, and if they had 
a history of or currently used alcohol or drugs. If they had a history of use and if they used 
alcohol regularly i.e., more than 2-3 days per week, they were informed they did not meet criteria 
for the study. If there was any doubt of alcohol or drug use, they were not asked to participate in 
this study. 
Exploratory data analysis was run for age which provided the mean, standard deviation, 
percentage, number, and the minimum and maximum age along with the age range. The sample 
demographics as presented in Table 1, reflect that the participants in both groups were of similar 




















    Male 



















    In years, M (SD) 33.22 (8.141) 33.26 (7.978)  
    Range 20-47 20-46  
Ethnicity    
    NZ European 14 (30.4%) 16 (34.8%) 30 (65.2%) 
    NZ Maori 2 (4.3%) 5 (10.9%) 7 (15.2%) 
    European 5 (10.9%) 1 (2.2%) 6 (13.0%) 
    Other 2 (4.3%) 1 (2.2%) 3 (6.5%) 
Marital status    
    Single 11 (23.9%) 15 (32.6%) 26 (56.5%) 
    Married / De-facto 8 (17.4%) 3 (6.5%) 11 (23.9%) 
    In relationship 4 (8.7%) 5 (10.9%) 9 (19.6%) 
Education    
    Did not complete High School 0 (0.0%) 7 (15.2%) 7 (15.2%) 
    Completed High School 1 (2.2%) 3 (6.5%) 4 (8.7%) 
    School Certificate / NCEA1 6 (13.0%) 7 (15.2%) 13 (28.3%) 
    Certificate 3 (6.5%) 5 (10.9%) 8 (17.4%) 
    Diploma 4 (8.7%) 1 (2.2%) 5 (10.9%) 
    Degree 6 (13.0%) 0 (0.0%) 6 (13.0%) 
    Masters 3 (6.5%) 0 (0.0%) 3 (6.5%) 
 
Note. NZ refers to New Zealand. 
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The participants in the control group (N = 23) were aged between 20 and 47 years old 
with a mean age of 33.22 (SD = 8.14), and the participants in the drug group (N = 23) were aged 
between 20 and 46 years old with a mean age of 33.26 (SD = 7.98). A one-way ANOVA showed 
no significant difference in age between groups, F(1, 44) = .000, p = .985. 
The demographics of ethnicity shows the total number and percentages of participants in 
each category (NZ European, NZ Maori, European, other), and for each group (control and 
drug). Ethnicity was similar in both groups with the majority, 65% of all participants (control 
group N = 14, drug group N = 16), responding as New Zealand European, with 7% of all 
participants identifying as New Zealand Maori. There was a small difference between groups for 
those identifying as New Zealand Maori with N = 2 (4.3%) in the control group and N = 5 
(10.9%) in the drug group.  
Another difference was also noted for those identifying as European with N = 5 (10.9%) 
in the control group and only N = 1 (2.2%) in the drug group. Very little difference was found for 
those identifying as ‘other’ for ethnicity with only N = 2 (4.3%) in the control group and N = 1 
(2.2%) in the drug group. Ethnicity for the drug group could be seen as a presentation of the 
those presenting for AOD treatment at the men’s residential facility. When it came to recruitment 
of the control group, ethnicity was difficult to govern for.  
For marital status (single, married or de-facto, in relationship) it can be seen in Table 1, 
that the majority of participants in both groups were ‘single’ with little difference found between 
each group: control group N = 11 (23.9%) and drug group N = 15 (32.6%), making a total of N = 
26 (56.5%) of all participants’ marital status as ‘single’. Very little difference was also noted for 
‘in relationship with N = 4 (8.7%) in the control group and N = 5 (10.9%) in the drug group. 
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However, there was a notable difference in ‘married’ participants with N = 8 (17.4%) in the 
control group and only N = 3 (6.5%) in the drug group.  
For highest education level achieved (did not complete high school, completed high 
school, school certificate / NCEA1, certificate, diploma, degree, masters), there were 
considerable differences found between groups for these categories with N = 0 of the control 
group compared to N = 7 (15.2%) of the drug group having ‘not completed high school’. There 
were similarities found for ‘completed high school’ with N = 1 (2.2%) of the control group 
compared to N = 3 (6.5%) of the drug group; and ‘school certificate / NCEA1’ showing N = 6 
(13%) of the control group compared to N = 7 (15.2%) of the drug group. 
There were similar results found again between groups for ‘certificate’ with N = 3 (6.5%) 
of the control group compared to N = 5 (10.9%) of the drug group; and ‘diploma’ showing N = 4 
(8.7%) of the control group compared to N = 1 (2.2%) of the drug group. There were larger 
differences found between groups for ‘degree’ which showed N = 6 (13.0%) of the control group 
compared to N = 0 of the drug group; and N = 3 (6.5%) of the control group compared to N = 0 
of the drug group having obtained a ‘masters’. Overall, the control group had an increased 
prevalence of higher education qualifications. 
Part of the criteria for the control group was for participants to have no history of drug 
use, drug addiction or problematic drug use, and no use of AOD services or facilities in any 
capacity. The inclusion criteria for the drug group was: (a) aged between 20 and 50 years old, (b) 
have a history of drug use of more than two years, (c) undergoing treatment for SUD at a 
residential AOD treatment facility at the time of data collection, (d) being detoxed by at least one 
week with verification by drug tests at the residential AOD facility, and (e) a current diagnosis 




The medications reported by both groups were placed into the following categories: 
antidepressants, antipsychotics (quetiapine only), epileptic / anticonvulsant, and benzodiazepines 
and are displayed in Table 2.  
 
Table 2 






Medication   
    Anti-depressants 0 6 
    Anti-psychotic (quetiapine) 0 3 
    Anti-epileptic/convulsant 1 2 
    Benzodiazepines 0 1 
    No Medication 22 14 











Substance of choice 
Substances used (1st and 2nd choice) by the drug group were placed under the categories 
of alcohol, Cannabis, stimulants, benzodiazepines and opiates and are displayed in Table 3. 
 
Table 3 
Comparisons on substance of choice for the drug group. 
 
Substance of choice 1 
N (%) 
Substance of choice 2 
N (%) 
N 23 (100%) 19 (82.6%) 
Substance   
    Alcohol 6 (26.1%) 2 (10.5%) 
    Cannabis 3 (13.0%) 9 (47.4%) 
    Stimulants 6 (26.1%) 7 (36.8%) 
    Benzodiazepines 2 (8.7%) 0 
    Opiates 6 (26.1%) 1 (5.3%) 
 
Measures 
Substance Use Disorder. All of the participants in the drug group met the DSM-5’s 
criteria for SUD and were previously diagnosed by the AOD residential treatment facility prior 
to recruitment for this study. All participants recruited from the AOD facility met all the criteria 
for the drug group.  
Demographics. The demographic questionnaire consisting of eight questions which 
included age, ethnicity, marital status, education level, and current medications (the drug group 
were also asked what their main drug of choice or use was, and what other drugs they also used). 
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Impulsivity. Personality facets of impulsivity were measured using the revised UPPS-P 
Impulsive Behavior Scale (Lynam et al., 2006). This questionnaire is a revised scale of the 
original UPPS Impulsivity Behavior Scale (Whiteside & Lynam, 2009) which was the result of 
exploratory and confirmatory factor analysis along with testing and reporting of internal 
consistency and external validity.  
The UPPS-P Impulsive Behavior Scale (Lynam et al., 2006) questionnaire comprises of 
59 items designed to measure five distinct personality facets of impulsivity behaviours. The 
items were rated on a 4-point scale - (1) agree strongly, (2) agree some, (3) disagree some, and 
(4) disagree strongly. Higher scores indicate greater impulsive behaviour. The scores for the 
UPPS-P Impulsive Behavior Scale (Lynam et al., 2006) are presented for each of the five 
subscales as follows: 
(a) Negative urgency (the tendency to experience and act upon strong impulses under 
conditions of negative affect), e.g., “When I feel bad, I will often do things I later 
regret in order to make myself feel better now”;  
(b) Lack of premeditation (a lack of ability to think and reflect on consequences of an 
action before engaging in it), e.g., “I like to stop and think things over before I do 
them”; 
(c) Lack of perseverance (difficulties remaining focused on a task that may be seen as 
long, boring, or difficult), e.g., “I tend to give up easily”; 
(d) Sensation-seeking (a tendency to enjoy and pursue exciting activities, and an 
openness to trying new experiences and sensations that may be risky or dangerous), 
e.g., “I’ll try anything once”; and 
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(e) Positive urgency (tendency towards rash action in response to a very positive mood), 
e.g., “When I am very happy, I can’t seem to stop myself from doing things that can 
have bad consequences”.  
Attention Deficit Hyperactivity Disorder. The Adult ADHD Self-Report Scale (ASRS-
v1.1) (Kessler et al., 2005) was used to determine if symptoms of ADHD were present and their 
severity. The questionnaire was designed to stimulate dialogue and is a self-report measure that 
consists of two parts totalling 18 questions taken from the diagnostic criteria of ADHD from the 
DSM-IV-TR. Six of the questions (Part A) are more predictive of the symptoms associated with 
ADHD, are clinically significant and are used as a screening instrument. Part B consists of a 
further 12 questions which provide additional cues into the symptoms and severity of ADHD. 
Participants responded to all items of the Adult ADHD Self-Report Scale (ASRS-v1.1) 
(Kessler et al., 2005) on a five-point Likert scale (0 = never, 1 = rarely, 2 = sometimes, 3 = often, 
4 = very often). A response of 3 or 4 indicated that the symptom is clinically significant while for 
three items (how often do you have trouble wrapping up the final details of a project, once the 
challenging parts have been done; how often do you have difficulty getting things in order when 
you have to do a task that requires organization; and how often do you have problems 
remembering appointments or obligations?) a response of 2 is also clinically significant. The 
presence of adult ADHD is confirmed if the participant responds in the category of clinically 
significant for 4 more items in part A. This scale has been found to have a range of 0.63-0.72 for 
internal consistency reliability along with a range of 0.58-0.77 for (Pearson correlations) test-






The study and the procedures received approval from the University of Canterbury’s 
Human Ethics Committee and the Clinical Director of the AOD treatment facility. Recruitment 
of the control group participants was from the general public which involved placing fliers 
around the University of Canterbury and other places such as libraries and public notice boards. 
The drug group participants were recruited at the residential AOD treatment facility where they 
were given a group presentation outlining what the study was about and what would be expected 
of them. All potential participants were provided with information about the study and all 
questions were answered. All participants were made aware that participation was completely 
voluntary and were under no pressure to participate. During the consenting process, all 
participants were assured of their anonymity and confidentiality throughout and following the 
study. 
Both groups were informed that if they completed the study they would be given a $20 
voucher for a local supermarket. For the residential AOD treatment facility participants, a private 
consulting room was used at the facility. For the control group the interviews took place in 
private consulting room at the University of Canterbury. All participants were provided with 
written material by way of an information sheet (Appendix A and B) about the study and written 
consent (Appendix C) was obtained prior to commencement of any collection of data.  
Once consent had been obtained in writing the interview process took place which 
involved the completion of three questionnaires in random order: the Demographics (Appendix 
D), the UPPS-P Impulsive Behavior Scale (Lynam et al., 2006) (Appendix E), and the Adult 
ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist (Kessler et al., 2005) (Appendix F). 
Permission was sought and obtained for use of the Adult ADHD Self-Report Scale (ASRS-v1.1) 
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Symptom Checklist (Kessler et al., 2005) from the office of Dr Kessler at Harvard Medical 
School (Boston, USA).  
The questionnaires were administered orally in the style of a clinical interview to ensure 
the questions were understood, and the researcher recorded the answers. The interviews took 
approximately 30 – 45 minutes to complete and participants were encouraged to seek assistance 
if the questions were unclear. All participants completed the same three questionnaires: (a) The 
demographic questionnaire; (b) The UPPS-P Impulsive Behavior Scale (Lynam et al., 2006) 
consisting of 59 consisting of five subscales that assess positive urgency, negative urgency, (lack 
of) premeditation, (lack of) perseverance and sensation seeking; and (c) The Adult ADHD Self-
Report Scale (ASRS-v1.1) Symptom Checklist (Kessler et al., 2005) involving 18 questions 
derived from the DSM-IV criteria for ADHD confirming the symptoms and measuring the 
severity of the symptoms of ADHD.    
 
Analysis 
Data was analysed using IBM SPSS Statistics (Version 22.0) for Windows. Bivariate 
descriptive statistics were used to highlight the mean, standard deviation, and minimum and 
maximum on the continuous variables: age in years, negative urgency score, lack of 
premeditation score, lack of perseverance score, sensation score, positive urgency score, ADHD 
Part A score, and ADHD total of Part A and B score. 
A one-way ANOVA was run to detect if there were any significant differences between 
groups on age in years. Chi-Square tests were not run on ethnicity, marital status, medication use 
(antidepressants, antipsychotics, anti-epileptic/anticonvulsant, benzodiazepines), or substances 
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used (alcohol, Cannabis, stimulants, benzodiazepines, opiates) due to low cell counts in several 
groups. 
A MANOVA was run on ADHD Part A scores and ADHD total of Part A and B scores to 
compare the means across the two groups (drug and control).  Then a MANOVA was run to 
determine if there were any significant differences between groups (drug and control) on 
impulsivity subscales (negative urgency, lack of premeditation, lack of perseverance, sensation 
seeking, positive urgency).  
MANOVA’s were also run on the drug group for the impulsivity subscales for those 
taking versus not taking medications, and those using versus not using stimulants and Cannabis. 
The same test was run on the ADHD measures for the continuous variables (i.e., subscale 
scores). Chi-Squared was run on the ADHD diagnosis (present, absent) and specific drug use 
(yes, no) to see if there was a relationship between the positive diagnosis of ADHD and a 
















Descriptive statistics for each group (control and drug) on the impulsivity subscales are 
shown in Table 4. 
 
Table 4. 
Group comparisons for the five subscales of the UPPS-P Impulsive Behavior Scale (Lynam et 
al., 2006).  
 Control Group  Drug Group 
 M (SD) Min. Max.  M (SD) Min. Max. 
Negative Urgency 2.25 (.66) 1.08 3.58  3.49 (.36) 2.58 4.00 
Lack of Premeditation 2.12 (.56) 1.18 2.91  2.69 (.54) 1.73 3.73 
Lack of Perseverance 1.96 (.49) 1.10 3.00  2.42 (.53) 1.20 3.40 
Sensation Seeking 2.96 (.61) 2.00 3.83  3.37  (.51) 2.17 4.00 
Positive Urgency 1.96 (.66) 1.14 3.50  3.10 (.63) 1.50 4.00 
 
 
MANOVA showed a significant multivariate effect across group for the impulsivity 
scale, F(5, 40) = 11.83, p <.001, ηp
2 = .60. Univariate analysis showed the groups differed on 
Negative Urgency, F(1, 44) = 62.56, p < .001, ηp
2 = .59; Lack of Premeditation, F(1, 44) = 12.61, 
p = .001, ηp
2 = .22; Lack of Perseverance, F(1, 44) = 9.72, p = .003, ηp
2 = .81; Sensation Seeking, 
F(1, 44) = 6.21, p = .017, ηp
2 = .12; and Positive Urgency, F(1, 44) = 35.89, p < .001, ηp
2 = .45. 
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Isolating the drug group, MANOVA was run on the impulsivity subscales for those on 
medications versus not on any medications. There were no significant differences in multivariate 
effect F(5, 17) = 2.05, p = .122, ηp
2 = .38. A similar analysis on the drug group looking at 
differences in impulsivity subscales for those 1) using or not using stimulants, and 2) using and 
not using cannabis, also found no multivariate effects, F(5, 17) = .32, p = ..895, ηp
2 = .09, F(5, 
17) = 1.17, p = .366, ηp
2 = ..26, respectively. 
 
ADHD 
Chi-squared analysis showed higher levels of ADHD diagnosis in the drug group (yes = 
19, 83%; no = 4, 17%) than the control group (yes = 6, 26%; no = 17, 74%), 2(1, N = 46) = 
14.81, p < . 001. Table 5 shows descriptive statistics for the ADHD scale. 
 
Table 5. 
Group comparisons of the Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist 
(Kessler et al., 2005) for Part A, and the total of Part A and B. 
 Control Group  Drug Group 
 M (SD) Min. Max.  M (SD) Min. Max. 
ADHD Part A 10.17 (4.33) 2.00 16.00  15.70 (3.82) 8.00 23.00 






MANOVA compared groups (control and drug) for the ADHD scores for Part A and total 
of Part A and B. There was a multivariate effect, F(2, 43) = 14.76, p < .001, ηp
2 = .41. The drug 
group had higher scores on both Part A, F(1, 44) = 21.01, p < .001, ηp
2 = .32, and Parts A and B 
combined, F(1, 44) = 29.78, p < .001, ηp
2 = .40.  
For the drug group alone, MANOVA was run on ADHD scores for Part A and total of 
Part A and B for those on medications versus not on any medications. There were no 
multivariate effect found, F(2, 20) = .08, p = .920, ηp
2 = .01.  
Chi-Squared showed no significant relationship in the drug group for the ADHD 
diagnosis and stimulant use (ADHD+: yes = 19; no = 4; stimulant: yes = 10; no = 9),  2(1, N  = 
23) = .67, p = .412, or Cannabis use (ADHD+: yes = 19; no = 4; Cannabis: yes = 11; no = 8), 
2(1, N = 23) = 1.43, p = .231. 
 MANOVA showed no significant multivariate effect on ADHD scores Part A and total 
of Part A and B for those using or not using stimulants, F(2, 20) = 1.16, p = .335, ηp
2 = .09; and 
those using or not using Cannabis, F(2, 20) = 1.48, p = .251, ηp














The aim of this study was to determine if a history of more than two years of alcohol or 
drug use and a current diagnosis of SUD is related to higher rates of impulsivity and ADHD, 
compared to age-matched men with no SUD history who had similar ethnicities and relationship 
statuses. Results supported the hypotheses that a history of alcohol and drug use along with a 
diagnosis of SUD is related to higher impulsive behaviours and symptoms of ADHD. These 
findings are supported and build on previous research on impulsive behaviours and ADHD in 
those with drug addictions (e.g., Kaye et al., 2013; Izquierdo & Jentsch, 2012; Weafer & Wit, 
2013; Li et al., 2012). Although the results of this study show similar results to previous 
literature mentioned, this research looked at the subscales of impulsivity along with the 
symptoms of ADHD, and the effect they have on SUD. 
The results supported the first hypothesis that SUD is related to higher ratings of 
impulsive behaviours. The drug group scored higher on all the subscales of the impulsivity 
behaviour scale: negative urgency, lack of premeditation, lack of perseverance, sensation seeking 
and positive urgency. Although the scores for the drug group were consistently higher on all 
subscales, negative and positive urgency scores were the highest for the drug group. Negative 
urgency is the tendency to feel and act upon strong impulses when experiencing conditions of 
negative effect, such as conflict with a significant other or work related stress. Whereas positive 
urgency is the desire to act upon strong impulses when in a very good mood. Both of these 
constructs demonstrate how an individual with elevated impulsive behaviours, would seek or 




Those with higher rates of impulsivity are likely to take rash action when experiencing 
either negative or positive stimuli, regardless of whether it is internal or external. This rash 
action may make it difficult to disrupt or abort movement towards drug and alcohol use. The 
findings suggest that when a person with an addiction to drugs is experiencing times of stress 
that may be either internal or external, they are likely to engage in impulsive behaviour, which 
activates their drug taking. This has serious implications on relapsing when an individual may be 
controlling their drug intake or attempting a period of abstinence. Therefore, a relapse is likely if 
stress of any kind is experienced or not managed in other ways. 
The results of this study also supported the second hypothesis that SUD is related to a 
higher prevalence of ADHD symptoms. The drug group scored significantly and consistently 
higher on both measures of the ADHD scale: Part A, and the total of Part A and B compared to 
the control group. It was also found that the drug group scored significantly higher than the 
control group for a positive diagnosis of ADHD. In addition to this, the results also demonstrated 
that the drug group, in which most participants were positive for the ADHD diagnosis, did not 
have a preference for any particular drug type. This could be interpreted that illicit drug users, 
with high symptomology of ADHD, do not have a preference or use a specific class of drugs for 
self-medication. Further research into this is needed. For example, a study that reports on the 
types of drugs being used by those with coexisting disorders of ADHD and SUD. 
Finally, the results showed that for both groups (control and drug), there was no 
interaction between those taking and not taking medications. In the drug group neither 
medication use or specific substance use produced higher impulsivity or ADHD scores. This 
suggests impulsivity and ADHD symptoms are related to abusing substances generally, rather 
than a specific drug or medication use. There is a lot of research indicating that ADHD is related 
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to an earlier onset of drug use and higher severity of SUD (Kaye et al., 2013). Although it has 
been suggested that treatment of childhood ADHD may be beneficial with the prevention of 
illicit drug use in adulthood (Garcia, 2013). Unfortunately, diagnosis of ADHD is often 
overlooked, leaving the symptoms unmanaged and untreated psychologically or 
pharmacologically. Research also indicates that ADHD is not commonly diagnosed among those 
presenting for AOD treatment or with those diagnosed with SUD (Garcia, 2013). 
 
Strengths and Limitations 
Future research on ADHD, impulsivity and SUD should control for education as this 
study showed there was a significant difference between the control group and the drug group. 
The control group had a higher education level. Whilst the sample were not representative, it is 
possible that the drug group participants who scored highly on ADHD symptoms, may have had 
the symptoms of ADHD as a child, which may or may not have been diagnosed, adequately 
managed, or treated. Functional impairments in academic achievement are also seen in those 
with ADHD (Molina et al., 2014).  
Future work needs to examine, 1) the history of ADHD in SUD patients, 2) their impact 
on education, and 3) are these symptoms directly related to SUD development. A further 
limitation of this study is not controlling for Conduct Disorder (CD) which may play an 
important role in clarifying the connection between ADHD, impulsivity and SUD. In addition, 
ADHD shares similar features to CD therefore it would be worth controlling for CD in future 





Considerations for future research 
It would be very useful for future studies to look more closely at the relationship between 
ADHD and impulsivity. Although impulsivity is a trait of ADHD, a diagnosis of ADHD alone 
does not fully explain the interaction between these two constructs. It could be found in future 
research that only specific traits of impulsive behaviour (e.g., negative urgency/delay 
discounting) are prevalent in those diagnosed with ADHD. Given that previous research on 
ADHD and SUD has shown there is positive outcomes for residential patients with coexisting 
disorders of ADHD and SUD using non-pharmacological treatment methods (Matthys et al., 
2013), further research would certainly be worthwhile. 
 
Implications for SUD assessment and treatment  
If providers of AOD treatment were to screen for ADHD symptoms and impulsive 
behaviours, it may guide and improve treatment strategies. This would then result in far more 
effective treatment and lower rates of relapse. 
 
Conclusion 
With the severity of alcohol and drug addiction so high not only in New Zealand but 
worldwide, it is an area that is certainly worthy of further research. The costs are phenomenal 
both financially and for all involved. The current study has shown that impulsive behaviours and 
ADHD symptoms are indeed related to SUD and has built on previous research in this area. This 
research also looked at both impulsive behaviours and ADHD symptoms together, along with 
their effect on SUD. The finding of this study encourage future research to contribute further 
evidence towards the specific facets of impulsivity along with the symptoms of ADHD in those 
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with SUD. Such research will continue to guide assessment and treatment strategies for AOD 
workers and service providers. Improvements in these areas will result in fewer relapses, and 
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Appendix A  
(control group) 
College of Science 
Department of Psychology 
Tel: +64 3 364 2382, Fax: + 64 364 2181 
Email: sjm346@uclive.ac.nz 
Date ________________________________  
 
 
“The effect that ADHD symptoms and impulsivity  




Information Sheet for ________________________________________________________ 
  
 
My name is Suzanne McLaughlin. I am a Masters Thesis student at the University of Canterbury 
in Christchurch working under the supervision of Associate Professor Martin Dorahy and Dr 
Juan Canales. I am trying to understand more about drug use and dependence by conducting a 
study in which I gather information (data) from participants by asking questions and inviting 
them to complete questionnaires. 
 
This research will explore the impact that Attention Deficit Hyperactivity Disorder (ADHD) 
symptoms and impulse behaviours have on drug addiction. Other demographic factors will also 
be recorded such as gender and ethnicity. It is intended that this research will provide useful 
information for practitioners working in the alcohol / drug field which may improve assessment 
tools and guide treatment strategies. 
 
As part of this project I will be collecting data from participants’ by inviting them to complete a 
short demographic questionnaire and two other questionnaires on ADHD symptoms and 
impulsivity. This will be done in the style of an interview.  
 
If you would like to be involved, an appointment will be made with you at the University of 
Canterbury in a private consulting room. I will read the questions out to you and record your 
answers. There will be an opportunity to review your answers at the conclusion of the interview, 
however no feedback on your answers or diagnoses will be offered. It is estimated that collecting 
the data may take up to one hour. On completion of the questionnaires, you will be given a $20 





The use of your information 
 
Participation is voluntary and you have the right to withdraw at any stage without penalty. If you 
withdraw, all information relating to you will be removed. However, once the research has been 
completed and all the data merged together it will not be possible to remove your data as it will 
be anonymously placed in a data file.  
 
To ensure anonymity and confidentiality, your name will not be written on the questionnaires. 
Instead you will be assigned an identity number and this number will be written on your 
questionnaires.  
 
The completed questionnaires’ and consent form will be locked in separate cabinets in my 
supervisor’s university office (Martin Dorahy). The questionnaires, consent form and 
computerised data will be destroyed after five years in compliance with university requirements. 
 
A thesis is a public document and will be made available through the UC Library. The results of 
the project may be published, but you may be assured of the complete confidentiality of data 
gathered in this research. Your identity will only be known by the researcher Suzanne 
McLaughlin and will not be made public.   
 
The project is being carried out as a requirement of completing a Masters degree in Science 
(Psychology) by Suzanne McLaughlin the principal researcher under the supervision of 
Associate Professor Martin Dorahy and Dr Juan Canales. Suzanne McLaughlin can be contacted 
on phone number: 03 364 2382 or email: sjm346@uclive.ac.nz, and Martin Dorahy on phone 
number: 03 364 3416 or email: martin.dorahy@canterbury.ac.nz. They will be pleased to discuss 
any concerns you may have about participation in the project.  
 
This project has been reviewed and approved by the University of Canterbury Human Ethics 
Committee, and participants should address any complaints to: The Chair, Human Ethics 
Committee, University of Canterbury, Private Bag 4800, Christchurch or email: human-
ethics@canterbury.ac.nz.  
 
You may receive a copy of the research results at the conclusion of the project by indicating this 
on the consent form. 
 
If you agree to participate in the study, you are asked to complete the consent form with the 
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Information Sheet for ________________________________________________________ 
  
 
My name is Suzanne McLaughlin. I am a Masters Thesis student at the University of Canterbury 
in Christchurch working under the supervision of Associate Professor Martin Dorahy and Dr 
Juan Canales. I am trying to understand more about drug use and dependence by conducting a 
study in which I gather information (data) from participants by asking questions and inviting 
them to complete questionnaires. 
 
This research will explore the impact that Attention Deficit Hyperactivity Disorder (ADHD) 
symptoms and impulse behaviours have on drug addiction. Other demographic factors will also 
be recorded such as gender and ethnicity. It is intended that this research will provide useful 
information for practitioners working in the alcohol / drug field which may improve assessment 
tools and guide treatment strategies. 
 
As part of this project I will be collecting data from participants’ by inviting them to complete a 
short demographic questionnaire and two other questionnaires on ADHD symptoms and 
impulsivity. This will be done in the style of an interview.  
 
If you would like to be involved, an appointment will be made with you at Odyssey House in a 
private consulting room. I will read the questions out to you and record your answers. There will 
be an opportunity to review your answers at the conclusion of the interview, however no 
feedback on your answers or diagnoses will be offered. It is estimated that collecting the data 
may take up to one hour. On completion of the questionnaires, you will be given a $20 voucher 





The use of your information 
 
Participation is voluntary and you have the right to withdraw at any stage without penalty. If you 
withdraw, all information relating to you will be removed. However, once the research has been 
completed and all the data merged together it will not be possible to remove your data as it will 
be anonymously placed in a data file.  
 
To ensure anonymity and confidentiality, your name will not be written on the questionnaires. 
Instead you will be assigned an identity number and this number will be written on your 
questionnaires.  
 
The completed questionnaires’ and consent form will be locked in separate cabinets in my 
supervisor’s university office (Martin Dorahy). The questionnaires, consent form and 
computerised data will be destroyed after five years in compliance with university requirements. 
 
A thesis is a public document and will be made available through the UC Library. The results of 
the project may be published, but you may be assured of the complete confidentiality of data 
gathered in this research. Your identity will only be known by the researcher Suzanne 
McLaughlin and will not be made public.   
 
The project is being carried out as a requirement of completing a Masters degree in Science 
(Psychology) by Suzanne McLaughlin the principal researcher under the supervision of 
Associate Professor Martin Dorahy and Dr Juan Canales. Suzanne McLaughlin can be contacted 
on phone number: 03 364 2382 or email: sjm346@uclive.ac.nz, and Martin Dorahy on phone 
number: 03 364 3416 or email: martin.dorahy@canterbury.ac.nz. They will be pleased to discuss 
any concerns you may have about participation in the project.  
 
This project has been reviewed and approved by the University of Canterbury Human Ethics 
Committee, and participants should address any complaints to: The Chair, Human Ethics 
Committee, University of Canterbury, Private Bag 4800, Christchurch or email: human-
ethics@canterbury.ac.nz.  
 
You may receive a copy of the research results at the conclusion of the project by indicating this 
on the consent form. 
 
If you agree to participate in the study, you are asked to complete the consent form with the 
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Consent Form for ___________________________________________________________ 
 
I have been given a full explanation of this project and I have had the opportunity to ask 
questions. I understand that participation is voluntary and I may withdraw at any time prior to 
my data being merged with other data.   
 
I understand that any information or opinions I provide will be kept confidential to the researcher 
and the supervisor and that any published or reported results will not identify me. I understand 
that a thesis is a public document and will be available through the UC Library.   
 
I understand that all data collected for the study will be kept in locked secure facilities and 
password protected electronic form, and will be destroyed after five years. I understand the risks 
associated with taking part and how they will be managed.  
 
I understand that if I require further information I can contact the researcher Suzanne 
McLaughlin on phone number: 03 364 2382 or email: sjm346@uclive.ac.nz, or the supervisor 
Martin Dorahy on phone number: 03 364 3416 or email: martin.dorahy@canterbury.ac.nz.  
 
If I have any complaints, I can contact the Chair of the University of Canterbury Human Ethics 
Committee, Private Bag 4800, Christchurch or email: human-ethics@canterbury.ac.nz. 
 
Please tick if you would like to receive a copy of the report outlining the findings of the 
study by post or email to the following address:  
 
 












RE: Permission to use the ASRS-V1.1 in a New Zealand study 
 
From: Borreliz, Avery [Borreliz@hcp.med.harvard.edu] 
 
Sent: Sat 11/04/2015 5:32 a.m. 
 
To: Suzanne McLaughlin 
 
Thank you for contacting Dr. Kessler regarding the use of the ADHD-ASRS v1.1.  
Use of the ASRS is free and does not require any formal permission or approval. We do, 
however, ask that you please cite the below article when using the ASRS. Should you publish 
any work that uses the ASRS, please send us the citations to all final publications. 
 
Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M.J., Jin, R., 
Secnik, K., Spencer, T., Ustun, T.B., Walters, E.E. (2005). The World Health Organization Adult 
ADHD Self-Report Scale (ASRS). Psychological Medicine, 35(2), 245-256 
 
Should you make any amendments to the ASRS, please be sure to indicate those changes as 
being unique to your replication of the instrument. Please feel free to follow-up with me should 







Department of Health Care Policy 
Harvard Medical School 
180A Longwood Ave. 
















Gender:  Male / Female / Other     
 
 
Age:  _________________ 
 
 
Ethnicity: (you may circle more than one) 
 
 
NZ European / NZ Maori / European / Other: _____________________________________ 
 
 
Marital Status:  Single / Married or De-facto / In Relationship 
 
 
Education level:  Didn’t complete High School / Completed High School / School  
 
 
Certificate or NCEA1 / Certificate / Diploma / Degree / Masters 
 
 




Drug group only 
 




2nd Substance of Choice:  _____________________________________________________ 












UPPS-P Impulsive Behavior Scale 
 
Below are a number of statements that describe ways in which people act and think. For each statement, please indicate how much you 
agree or disagree with the statement. If you Agree Strongly circle 1, if you Agree Somewhat circle 2, if you Disagree Somewhat 
circle 3, and if you Disagree Strongly circle 4.  Be sure to indicate your agreement or disagreement for every statement below.  
 
Agree Agree Disagree Disagree 
Strongly Some Some Strongly  
1. I have a reserved and cautious attitude toward life. 
2. I have trouble controlling my impulses. 
3.  I generally seek new and exciting experiences and sensations. 
4. I generally like to see things through to the end. 
5.  When I am very happy, I can’t seem to stop myself from doing things 
that can have bad consequences. 
6. My thinking is usually careful and purposeful. 
7.  I have trouble resisting my cravings (for food, cigarettes, etc.). 
8.  I'll try anything once. 
9. I tend to give up easily. 
10. When I am in great mood, I tend to get into situations that could cause 
me problems. 
11. I am not one of those people who blurt out things without thinking. 
12. I often get involved in things I later wish I could get out of. 
13. I like sports and games in which you have to choose your next move 
very quickly. 
14. Unfinished tasks really bother me. 
15. When I am very happy, I tend to do things that may cause problems in 
my life. 
16. I like to stop and think things over before I do them. 
17. When I feel bad, I will often do things I later regret in order to make 
myself feel better now.   
18. I would enjoy water skiing. 
19. Once I get going on something I hate to stop. 
20. I tend to lose control when I am in a great mood. 
21. I don't like to start a project until I know exactly how to proceed. 
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Agree Agree Disagree Disagree 
Strongly Some Some Strongly  
22. Sometimes when I feel bad, I can’t seem to stop what I am doing even 
though it is making me feel worse. 
23. I quite enjoy taking risks. 
24. I concentrate easily. 
25. When I am really ecstatic, I tend to get out of control.  
26. I would enjoy parachute jumping. 
27. I finish what I start. 
28. I tend to value and follow a rational, "sensible" approach to things. 
29. When I am upset I often act without thinking. 
30. Others would say I make bad choices when I am extremely happy about 
something. 
31. I welcome new and exciting experiences and sensations, even if they are 
a little frightening and unconventional. 
32. I am able to pace myself so as to get things done on time. 
33. I usually make up my mind through careful reasoning. 
34. When I feel rejected, I will often say things that I later regret. 
35. Others are shocked or worried about the things I do when I am feeling 
very excited. 
36. I would like to learn to fly an airplane. 
37. I am a person who always gets the job done. 
38. I am a cautious person. 
39. It is hard for me to resist acting on my feelings. 
40. When I get really happy about something, I tend to do things that can 
have bad consequences. 
41. I sometimes like doing things that are a bit frightening. 
42. I almost always finish projects that I start. 
43. Before I get into a new situation I like to find out what to expect from it. 
44. I often make matters worse because I act without thinking when I am 
upset. 
45. When overjoyed, I feel like I can’t stop myself from going overboard. 
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1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
 
1 2 3 4 
 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
 
1 2 3 4 
1 2 3 4 
1 2 3 4 
1 2 3 4 
 
1 2 3 4 
1 2 3 4 
 
Please go to the next page 
52 
 
Agree Agree Disagree Disagree 
Strongly Some Some Strongly  
46. I would enjoy the sensation of skiing very fast down a high mountain 
slope. 
47. Sometimes there are so many little things to be done that I just ignore 
them all. 
48. I usually think carefully before doing anything. 
49. When I am really excited, I tend not to think of the consequences of my 
actions. 
50. In the heat of an argument, I will often say things that I later regret. 
51. I would like to go scuba diving. 
52. I tend to act without thinking when I am really excited. 
53. I always keep my feelings under control. 
54. When I am really happy, I often find myself in situations that I normally 
wouldn’t be comfortable with. 
55. Before making up my mind, I consider all the advantages and 
disadvantages. 
56. I would enjoy fast driving. 
57. When I am very happy, I feel like it is ok to give in to cravings or 
overindulge. 
58. Sometimes I do impulsive things that I later regret. 
59. I am surprised at the things I do while in a great mood. 
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This is a revised version of the UPPS Impulsive Behavior scale (Whiteside & Lynam, 2001). 
This version, UPPS-P (Lynam, Smith, Whiteside, & Cyders, 2006), assesses  Positive 
Urgency (Cyders, Smith, Spillane, Fischer, Annus, & Peterson, 2007) in addition to the four 
pathways assessed in the original version of the scale-- Urgency (now Negative Urgency), 
(lack of) Premeditation, (lack of) Perseverance, and Sensation Seeking. The scale uses a 1 
(agree strongly) to 4 (disagree strongly) response format. Because the items from different 
scales run in different directions, it is important to make sure that the correct items are 
reverse-scored. We suggest making all of the scales run in the direction such that higher 
scores indicate more impulsive behavior. Therefore, we include the scoring key for, 
(Negative) Urgency, (lack of) Premeditation, (lack of) Perseverance, Sensation Seeking, and 
Positive Urgency. For each scale, calculate the mean of the available items; this puts the 
scales on the same metric. We recommend requiring that a participant have at least 70% of 
the items before a score is calculated. 
 
(Negative) Urgency (all items except 1 are reversed) 
items 2 (R), 7(R), 12 (R), 17 (R), 22 (R), 29 (R), 34 (R), 39 (R), 44 (R), 50 (R), 53, 58 (R) 
 
(lack of) Premeditation (no items are reversed) 
items 1, 6, 11, 16, 21, 28, 33, 38, 43, 48, 55. 
 
(lack of) Perseverance (two items are reversed) 
items 4, 9 (R), 14, 19, 24, 27, 32, 37, 42, 47 (R) 
 
Sensation Seeking (all items are reversed) 
items 3 (R), 8 (R), 13 (R), 18 (R), 23 (R), 26 (R), 31 (R), 36 (R), 41 (R), 46 (R), 51 (R), 56 
(R) 
 
Positive Urgency (all items are reversed) 
items 5 (R), 10 (R), 15 (R), 20 (R), 25 (R), 30 (R), 35 (R), 40 (R), 45 (R), 49 (R), 52 (R), 54 
(R), 57 (R), 59 (R) 
 






Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist 
 
Name: _____________________________ Date: _____________________ 
Please answer the questions below, rating yourself on what best describes how you have felt and conducted 
yourself over the past 6 months. Please give this completed checklist to your healthcare professional to discuss 
during today’s appointment. 
 
Ratings: Never, Rarely, Sometimes, Often, Very often. 
 
Part A 
1. How often do you have trouble wrapping up the final details of a project, once the 
challenging parts have been done? 
2. How often do you have difficulty getting things in order when you have to do a task that 
requires organization?  
3. How often do you have problems remembering appointments or obligations? 
4. When you have a task that requires a lot of thought, how often do you avoid or delay 
getting started 
5. How often do you fidget or squirm with your hands or feet when you have to sit down for a 
long time?  
6. How often do you feel overly active and compelled to do things, like you were driven by a 
motor? 
Part B 
7. How often do you make careless mistakes when you have to work on a boring or difficult 
project?  
8. How often do you have difficulty keeping your attention when you are doing boring or 
repetitive work?  
9. How often do you have difficulty concentrating on what people say to you, even when they 
are speaking to you directly?  
10. How often do you misplace or have difficulty finding things at home or at work? 
11. How often are you distracted by activity or noise around you? 
12. How often do you leave your seat in meetings or other situations in which you are 
expected to remain seated?  
 
13. How often do you feel restless or fidgety? 
14. How often do you have difficulty unwinding and relaxing when you have time to 
yourself? 
15. How often do you find yourself talking too much when you are in social situations? 
16. When you’re in a conversation, how often do you find yourself finishing the sentences of 
the people you are talking to, before they can finish them themselves?  
17. How often do you have difficulty waiting your turn in situations when turn taking is 
required? 
18. How often do you interrupt others when they are busy? 
 
The Value of Screening for Adults with ADHD     
Research suggests that the symptoms of ADHD can persist into adulthood, having a 
significant impact on the relationships, careers, and even the personal safety of your patients 
who may suffer from it.1-4 Because this disorder is often misunderstood, many people who 
have it do not receive appropriate treatment and, as a result, may never reach their full 
potential. Part of the problem is that it can be difficult to diagnose, particularly in adults.    
The Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist was developed in 
conjunction with the World Health Organization (WHO), and the Workgroup on Adult 
ADHD that included the following team of psychiatrists and researchers:   
•  Lenard Adler, MD Associate Professor of Psychiatry and Neurology New York University 
Medical School   
•  Ronald C. Kessler, PhD Professor, Department of Health Care Policy Harvard Medical 
School   
•  Thomas Spencer, MD Associate Professor of Psychiatry Harvard Medical School   As a 
healthcare professional, you can use the ASRS v1.1 as a tool to help screen for ADHD in 
adult patients. Insights gained through this screening may suggest the need for a more in-
depth clinician interview. The questions in the ASRS v1.1 are consistent with DSM-IV 
criteria and address the manifestations of ADHD symptoms in adults. Content of the 
questionnaire also reflects the importance that DSM-IV places on symptoms, impairments, 
and history for a correct diagnosis.4   
The checklist takes about 5 minutes to complete and can provide information that is critical to 
supplement the diagnostic process.          
References: 1. Schweitzer JB, et al. Med Clin North Am. 2001;85(3):10-11, 757-777. 2. 
Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and 
Treatment. 2nd ed. 1998. 3. Biederman J, et al. Am J Psychiatry.1993;150:1792-1798. 4. 
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association. 2000: 
85-93.    
 
Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist Instructions 
The questions on the back page are designed to stimulate dialogue between you and your 
patients and to help confirm if they may be suffering from the symptoms of attention-
deficit/hyperactivity disorder (ADHD).   
Description:  The Symptom Checklist is an instrument consisting of the eighteen DSM-IV-
TR criteria.  Six of the eighteen questions were found to be the most predictive of symptoms 
consistent with ADHD.  These six questions are the basis for the ASRS v1.1 Screener and are 
also Part A of the Symptom Checklist.  Part B of the Symptom Checklist contains the 
remaining twelve questions.   
Instructions:   
Symptoms   
1. Ask the patient to complete both Part A and Part B of the Symptom Checklist by marking 
an X in the box that most closely represents the frequency of occurrence of each of the 
symptoms.    
2. Score Part A.  If four or more marks appear in the darkly shaded boxes within Part A then 
the patient has symptoms highly consistent with ADHD in adults and further investigation is 
warranted.     
3. The frequency scores on Part B provide additional cues and can serve as further probes 
into the patient’s symptoms.  Pay particular attention to marks appearing in the dark shaded 
boxes.  The frequency-based response is more sensitive with certain questions.  No total score 
or diagnostic likelihood is utilized for the twelve questions. It has been found that the six 
questions in Part A are the most predictive of the disorder and are best for use as a screening 
instrument.   
Impairments   
1. Review the entire Symptom Checklist with your patients and evaluate the level of 
impairment associated with the symptom.      
2. Consider work/school, social and family settings.      
3. Symptom frequency is often associated with symptom severity; therefore, the Symptom 
Checklist may also aid in the assessment of impairments.  If your patients have frequent 
symptoms, you may want to ask them to describe how these problems have affected the 
ability to work, take care of things at home, or get along with other people such as their 
spouse/significant other.     
History   
1. Assess the presence of these symptoms or similar symptoms in childhood.  Adults who 
have ADHD need not have been formally diagnosed in childhood.  In evaluating a patient’s 
history, look for evidence of early-appearing and long-standing problems with attention or 
self-control.  Some significant symptoms should have been present in childhood, but full 
symptomology is not necessary.   
